| Cholangiocarcinoma 2020: the next horizon in mechanisms and management JM Banales, JJG Marin, A Lamarca, PM Rodrigues, SA Khan, LR Roberts, ... Nature reviews Gastroenterology & hepatology 17 (9), 557-588, 2020 | 1497 | 2020 |
| Cholangiocarcinoma—evolving concepts and therapeutic strategies S Rizvi, SA Khan, CL Hallemeier, RK Kelley, GJ Gores Nature reviews Clinical oncology 15 (2), 95-111, 2018 | 1307 | 2018 |
| Pathogenesis, diagnosis, and management of cholangiocarcinoma S Rizvi, GJ Gores Gastroenterology 145 (6), 1215-1229, 2013 | 1265 | 2013 |
| Liver transplantation for “very early” intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment G Sapisochin, M Facciuto, L Rubbia‐Brandt, J Marti, N Mehta, FY Yao, ... Hepatology 64 (4), 1178-1188, 2016 | 297 | 2016 |
| Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma E Loeuillard, J Yang, ELN Buckarma, J Wang, Y Liu, C Conboy, ... The Journal of clinical investigation 130 (10), 5380-5396, 2020 | 204 | 2020 |
| Emerging molecular therapeutic targets for cholangiocarcinoma S Rizvi, GJ Gores Journal of hepatology 67 (3), 632-644, 2017 | 178 | 2017 |
| IL‐33 facilitates oncogene‐induced cholangiocarcinoma in mice by an interleukin‐6‐sensitive mechanism D Yamada, S Rizvi, N Razumilava, SF Bronk, JI Davila, MD Champion, ... Hepatology 61 (5), 1627-1642, 2015 | 135 | 2015 |
| Cholangiocarcinoma: molecular pathways and therapeutic opportunities S Rizvi, MJ Borad, T Patel, GJ Gores Seminars in liver disease 34 (04), 456-464, 2014 | 133 | 2014 |
| Primary sclerosing cholangitis as a premalignant biliary tract disease: surveillance and management S Rizvi, JE Eaton, GJ Gores Clinical Gastroenterology and Hepatology 13 (12), 2152-2165, 2015 | 121 | 2015 |
| Immunobiology of cholangiocarcinoma E Loeuillard, CB Conboy, GJ Gores, S Rizvi JHEP Reports 1 (4), 297-311, 2019 | 96 | 2019 |
| A hippo and fibroblast growth factor receptor autocrine pathway in cholangiocarcinoma S Rizvi, D Yamada, P Hirsova, SF Bronk, NW Werneburg, A Krishnan, ... Journal of Biological Chemistry 291 (15), 8031-8047, 2016 | 86 | 2016 |
| Targeting cholangiocarcinoma JC Mertens, S Rizvi, GJ Gores Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (4 …, 2018 | 82 | 2018 |
| Animal models of cholangiocarcinoma E Loeuillard, SR Fischbach, GJ Gores, S Rizvi Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1865 (5), 982-992, 2019 | 72 | 2019 |
| Liver cancer immunity S Rizvi, J Wang, AB El‐Khoueiry Hepatology 73, 86-103, 2021 | 68 | 2021 |
| Emerging technologies for the diagnosis of perihilar cholangiocarcinoma S Rizvi, J Eaton, JD Yang, V Chandrasekhara, GJ Gores Seminars in liver disease 38 (02), 160-169, 2018 | 66 | 2018 |
| Supplementation with oral vs. intravenous iron for anemia with IBD or gastrointestinal bleeding: is oral iron getting a bad rap? S Rizvi, RE Schoen Official journal of the American College of Gastroenterology| ACG 106 (11 …, 2011 | 58 | 2011 |
| Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis S Rizvi, JC Mertens, SF Bronk, P Hirsova, H Dai, LR Roberts, ... Journal of Biological Chemistry 289 (33), 22835-22849, 2014 | 53 | 2014 |
| Sequence-specific recruitment of heterochromatin protein 1 via interaction with Krüppel-like factor 11, a human transcription factor involved in tumor suppression and metabolic … G Lomberk, AJ Mathison, A Grzenda, S Seo, CJ DeMars, S Rizvi, ... Journal of Biological Chemistry 287 (16), 13026-13039, 2012 | 52 | 2012 |
| Combinatorial chemoprevention reveals a novel smoothened-independent role of GLI1 in esophageal carcinogenesis S Rizvi, CJ DeMars, A Comba, VG Gainullin, Z Rizvi, LL Almada, K Wang, ... Cancer research 70 (17), 6787-6796, 2010 | 52 | 2010 |
| YAP-associated chromosomal instability and cholangiocarcinoma in mice S Rizvi, SR Fischbach, SF Bronk, P Hirsova, A Krishnan, R Dhanasekaran, ... Oncotarget 9 (5), 5892, 2018 | 51 | 2018 |
